Willow Biosciences Ownership
| CANSF Stock | USD 0.07 0 4.76% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Willow |
Willow OTC Stock Ownership Analysis
About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Willow Biosciences last dividend was issued on the 21st of May 2019. The entity had 1:25 split on the 21st of May 2019. Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada. Willow Biosciences is traded on OTC Exchange in the United States.The quote for Willow Biosciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Willow Biosciences please contact the company at 403 910 5140 or go to https://www.willowbio.com.Currently Active Assets on Macroaxis
Other Information on Investing in Willow OTC Stock
Willow Biosciences financial ratios help investors to determine whether Willow OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.